Thrombocytopenia and hemorrhagic risk in cancer patients

Critical Reviews in Oncology/Hematology

Volumn 48, Issue SUPPL., 2003, Pages

  Avvisati, Giuseppe ^a   Tirindelli, Maria Cristina ^a   Annibali, Ombretta ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Hemorrhagic risk; Thrombocytopenia; Tumor

Indexed keywords

ACETYLSALICYLIC ACID; ANTINEOPLASTIC AGENT; ASPRIN; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G;

BLEEDING; BLOOD CLOTTING; CANCER RISK; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; DRUG MEGADOSE; FEVER; HUMAN; INFECTION; MYELOID LEUKEMIA; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SAFETY; SOLID TUMOR; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

EID: 0141953219     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2003.04.001     Document Type: Conference Paper

References (16)

1. Gaydos L.A., Freireich E.J., Mantel N. The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. N. Engl. J. Med. 266:1962;905-909.
2. Ford JM: Should prophylactic platelets be given to patients with acute leukemia? In: Lister TA, Malpas JS, editors. Platelet transfusion. Baltimore, CO: University Park, 1980. p. 45-9.
3. Slichter S.J., Harker L.A. Thrombocytopenia: mechanisms and management of defects in platelet production. Clin. Haematol. 7:1978;523-539.
4. Solomon J., Bofenkamp T., Fahey J.L., Chillar R.K., Beutler E. Platelet prophylaxis in acute non-lymphoblastic leukemia. Lancet. 1:1978;267.
5. Belt R.J., Leite C., Haas C.D., Stephens R.L. Incidence of hemorrhagic complications in patients with cancer. J. Am. Med. Assoc. 239:1978;2571-2574.
6. Dutcher J.P., Schiffer C.A., Aisner J., O'Connell B.A., Levy C., Kendall J.A.et al. Incidence of thrombocytopenia and serious hemorrhage among patients with solid tumors. Cancer. 53:1984;557-562.
7. Goldberg G.L., Gibbon D.G., Smith H.O., Runowicz C.D., Burns E.R., DeVictoria C. Clinical impact of chemotherapy-induced thrombocytopenia in patients with gynecologic cancer. J. Clin. Oncol. 12:1994;2317-2320.
8. Fanning J., Hilgers R.D., Murray K.P., Bolt K., Aughenbaugh D.M. Conservative management of chemotherapeutic-induced thrombocytopenia in women with gynecologic cancers. Gynecol. Oncol. 59:1995;191-193.
9. Chang H.Y., Rodriguez V., Narboni G., Bodey G.P., Luna M.A., Freireich E.J. Causes of death in adult with acute leukemia. Medicine. 55:1976;259-268.
10. Schiffer C.A. Prophylactic platelet transfusion. Transfusion. 32:1992;295-298.
11. Beutler E. Platelet Transfusion: the 20,000/μl trigger. Blood. 81:1993;1411-1413.
12. Gmür J., Burger J., Schanz U., Fehr J., Schaffner A. Safety of stringent prophylactic platelet transfusion policy for patients with acute leukemia. Lancet. 338:1991;1223-1226.
13. Heckman K.D., Weiner G.J., Davis C.S., Strauss R.G., Jones M.P., Burns C.P. Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/μl versus 20,000/μl. J. Clin. Oncol. 15:1997;1143-1149.
14. Rebulla P., Finazzi G., Marangoni F., Avvisati G., Gugliotta L., Tognoni G.et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. N. Engl. J. Med. 337:1997;1870-1875.
15. 9/l trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. Blood. 91:1998;3601-3606.
16. Schiffer CA, Anderson KC, Bennett CL, Bernstein S, Elting LS,Goldsmith M, et al. Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001;19:1519-38.